English Ukrainian
Experemental medicine

EFFECT OF NEUROPROTECTIVE THERAPY WITH CITICOLINE ON THE COURSE OF EXPERIMENTAL NON-INFECTIOUS ANTERIOR AND INTERMEDIATE UVEITIS

Published 2024-10-16

Authors:

O.V. Zborovska
I.S. Horіanova
V.O. Ulianov
O.E. Dorokhova
E.V. Maltsev
N.I. Molchaniuk
Abstract:
Non-infectious anterior and middle uveitis is a significant uveitis group, leading to decreased visual acuity and often blindness. The purpose of the study was to determine the features of the clinical course and morphological changes of the choroid, retina, and optic nerve in the early and late stages of experimental non-infectious anterior and middle uveitis under the conditions of neuroprotective citicoline therapy. We studied the clinical course of the disease and morphological changes on the 10–13th, and 33rd days after the administration of the provocative dose. The use of citicoline led to a decrease in inflammation in uveitis. First of all, due to reduced swelling of the cornea and iris. It was confirmed by histomorphological examination. It reduced the violation of the retinal cytoarchitectonic disturbances and degenerative and destructive changes in its neurons. It also reduced the swelling of the retina and optic nerve cells. It activated intracellular compensatory processes in the retina, particularly in the pigment epithelium and optic nerve glial cells.
Keywords:
anterior uveitis intermediate uveitis experimental animal model choroid retina optic nerve citicoline
References:
  1. Alvarez-Guzman C, Bustamante-Arias A, Colorado-Zavala MF, Rodriguez-Garcia A. The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema. Int J Retina Vitreous. 2021 Apr 27;7(1):36. doi: 10.1186/s40942-021-00306-8.
  2. Dorokhova O E, Zborovska OV, Guanjun Meng. Relationship of the ocular surface temperature with the clinical features of induced non-infectious anterior and intermediate uveitis in rabbits. J.ophthalmol.(Ukraine).2020;6:38–43. http://doi.org/10.31288/oftalmolzh202063843.
  3. Fung S, Syed YY. Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema. Drugs. 2022 Sep;82(13):1403–1410. doi: 10.1007/s40265-022-01763-7.
  4. Jünemann AGM, Grieb P, Rejdak R. Bedeutung von Citicolin bei der Glaukomerkrankung [The role of citicoline in glaucoma]. Ophthalmologe. 2021 May;118(5):439–448. German. doi: 10.1007/s00347-021-01362-z. [in German]
  5. Laksmita YA, Sidik M, Siregar NC, Nusanti S. Neuroprotective Effects of Citicoline on Methanol-Intoxicated Retina Model in Rats. J Ocul Pharmacol Ther. 2021 Nov;37(9):534–541. doi: 10.1089/jop.2021.0018.
  6. Luceri S, Erba S, Casalino G. A Boy with Anterior Uveitis and Optic Disc Swelling. JAMA Ophthalmol. 2021 Dec 1;139(12):1313–1314. doi: 10.1001/jamaophthalmol.2021.1056.
  7. Okunukia Y, Mukaia R, Nakaob T, Tabora SJ, Butovskyc O, Danab R et al. Retinal microglia initiate neuroinflammation inocular autoimmunity.PNAS. 2019;116(20):9989–9998.
  8. Park CH, Kim YS, Cheon EW, Noh HS, Cho CH, Chung IY et al. Action of citicoline on rat retinal expression of extracellular-signal-regulated kinase (ERK1/2). Brain Res. 2006 Apr 7;1081(1):203–10. doi: 10.1016/j.brainres.2005.12.128.
  9. Santina A, Bousquet E, Somisetty S, Fogel-Levin M, Tsui E, Freund KB et al. Recurrent anterior uveitis associated with major fluctuations in choroidal thickness in a patient with pachychoroid disorder. Retin Cases Brief Rep. 2024 Sep 1;18(5):562–565. doi: 10.1097/ICB.0000000000001437.
  10. Secades JJ, Gareri P. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022 Nov 30;75(s05): S1–S89. doi: 10.33588/rn.75s05.2022311.
  11. Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A Focus on the Epidemiology of Uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi: 10.1080/09273948.2016.1196713.
  12. Valdes LM, Sobrin L. Uveitis Therapy: The Corticosteroid Options. Drugs. 2020 Jun;80(8):765–773. doi: 10.1007/s40265-020-01314-y.
  13. Wu X, Tao M, Zhu L, Zhang T, Zhang M. Pathogenesis and current therapies for non-infectious uveitis. Clin Exp Med. 2023 Aug;23(4):1089–1106. doi: 10.1007/s10238-022-00954-6.
  14. Yakymenko I, Ulyanova N, Shakun K. The development of glaucomous optic neuropathy prediction. Part I. Mathematical model of deformation of the lamina cribrosa and damage to nerve filaments in glaucoma. Oftalmologija. Vostochnaja Evropa. 2018;8(4):475–486.
Publication:
«World of Medicine and Biology» Vol. 20 No. 90 (2024) , с. 185-190
УДК 616.98-07:617.7:616.833-085:615.357:57.087.1
DOI:
https://doi.org/10.26724/2079-8334-2024-4-90-185-190